GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Other Current Receivables

Nuformix (LSE:NFX) Other Current Receivables : £0.00 Mil (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix Other Current Receivables?

Nuformix's Other Current Receivables for the quarter that ended in Sep. 2022 was £0.00 Mil.

Nuformix's annual Other Current Receivables declined from Mar. 2020 (£0.03 Mil) to Mar. 2021 (£0.02 Mil) but then increased from Mar. 2021 (£0.02 Mil) to Mar. 2022 (£0.17 Mil).


Nuformix Other Current Receivables Historical Data

The historical data trend for Nuformix's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Other Current Receivables Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Other Current Receivables
Get a 7-Day Free Trial 0.15 0.15 0.03 0.02 0.17

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 - 0.17 - -

Nuformix Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Nuformix Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Nuformix's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix (LSE:NFX) Business Description

Industry
Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.